- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) announces that it has been listed for trading on the OTCQB Market exchange. The company will continue to trade on the Toronto Stock Venture Exchange.
DiaMedica Inc. (TSX VENTURE:DMA)(OTCQB:DMCAF) announces that it has been listed for trading on the OTCQB Market exchange. The company will continue to trade on the Toronto Stock Venture Exchange.
According to the DiaMedica’s President and CEO Rick Pauls:
Trading on the OTCQB will expand the company’s presence in the United States and provide our existing shareholders in the U.S. with a transparent trading platform. Admission to the OTCQB exchange is part of our long-term strategy to introduce the company to a broader range of institutional and retail investors in the U.S.
Click here to read the fill press release from DiaMedica.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.